Literature DB >> 26688580

Neuroprotective effect of Myo/Nog cells in the stressed retina.

Arturo Bravo-Nuevo1, Alice A Brandli2, Jacquelyn Gerhart3, Jennifer Nichols4, Meghan Pitts4, Christopher K Sutera4, Sarah Assali4, Victoria Scheinfeld4, George C Prendergast4, Jonathan Stone2, Mindy George-Weinstein5.   

Abstract

Myo/Nog cells are essential for eye development in the chick embryo and respond to injury in adult tissues. These cells express mRNA for the skeletal muscle specific transcription factor MyoD, the bone morphogenetic protein (BMP) inhibitor Noggin and the cell surface protein recognized by the G8 monoclonal antibody (mAb). In this study, we determined that Myo/Nog cells are present in low numbers in the retina of the mouse eye. G8-positive Myo/Nog cells were distinguished from neuronal, Müller and microglial cells that were identified with antibodies to calretinin, Chx10, glial fibrillary acidic protein and ionized calcium binding adaptor molecule 1, respectively. In the neonatal retina, the number of Myo/Nog cells increased in parallel with cell death induced by transient exposure to hyperoxia. In this model of retinopathy of prematurity, depletion of Myo/Nog cells by intravitreal injection of the G8 mAb and complement increased cell death. These findings demonstrate that Myo/Nog cells are a distinct population of cells, not previously described in the retina, which increases in response to retinal damage and mitigate hypoxia-induced cell death.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Critical period; Myo/Nog cells; Oxygen-induced retinopathy; Photoreceptors; Retina

Mesh:

Substances:

Year:  2015        PMID: 26688580     DOI: 10.1016/j.exer.2015.11.023

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  6 in total

1.  Myo/Nog cells are present in the ciliary processes, on the zonule of Zinn and posterior capsule of the lens following cataract surgery.

Authors:  Jacquelyn Gerhart; Colleen Withers; Colby Gerhart; Liliana Werner; Nick Mamalis; Arturo Bravo-Nuevo; Victoria Scheinfeld; Paul FitzGerald; Robert Getts; Mindy George-Weinstein
Journal:  Exp Eye Res       Date:  2018-03-17       Impact factor: 3.467

Review 2.  Looking ahead: where to next for animal models of bronchopulmonary dysplasia?

Authors:  Claudio Nardiello; Ivana Mižíková; Rory E Morty
Journal:  Cell Tissue Res       Date:  2016-12-05       Impact factor: 5.249

3.  Role of Myo/Nog Cells in Neuroprotection: Evidence from the Light Damaged Retina.

Authors:  Alice Brandli; Jacquelyn Gerhart; Christopher K Sutera; Sivaraman Purushothuman; Mindy George-Weinstein; Jonathan Stone; Arturo Bravo-Nuevo
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

4.  Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage.

Authors:  Jacquelyn Gerhart; Jessica Bowers; Lindsay Gugerty; Colby Gerhart; Mark Martin; Fathma Abdalla; Arturo Bravo-Nuevo; Jonathan Tabb Sullivan; Rebecca Rimkunas; Amie Albertus; Lou Casta; Lori Getts; Robert Getts; Mindy George-Weinstein
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

5.  Rhabdomyosarcoma and Wilms tumors contain a subpopulation of noggin producing, myogenic cells immunoreactive for lens beaded filament proteins.

Authors:  Jacquelyn Gerhart; Kathryn Behling; Michele Paessler; LaBraya Milton; Gregory Bramblett; Denise Garcia; Meghan Pitts; Reginald Hurtt; Mitchell Crawford; Richard Lackman; Daniela Nguyen; Joseph Infanti; Paul FitzGerald; Mindy George-Weinstein
Journal:  PLoS One       Date:  2019-04-11       Impact factor: 3.240

6.  Acute Response and Neuroprotective Role of Myo/Nog Cells Assessed in a Rat Model of Focal Brain Injury.

Authors:  Sahlia Joseph-Pauline; Nathan Morrison; Michael Braccia; Alana Payne; Lindsay Gugerty; Jesse Mostoller; Paul Lecker; E-Jine Tsai; Jessica Kim; Mark Martin; Rushil Brahmbhatt; Grzegorz Gorski; Jacquelyn Gerhart; Mindy George-Weinstein; Jonathan Stone; Sivaraman Purushothuman; Arturo Bravo-Nuevo
Journal:  Front Neurosci       Date:  2021-12-07       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.